CBUS CIK: 1705843

Cibus, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−18.8
FY22:
−19.4
FY23:
−46.2
FY24:
−58.0
FY25:
−50.6
Change from FY21 to FY25
millions USD
FY21:
11.2
FY22:
−1.52
FY23:
55.1
FY24:
−0.81
FY25:
−0.58
Change from FY21 to FY25
millions USD
FY21:
3.74
FY22:
9.99
FY23:
20.3
FY24:
40.6
FY25:
46.6
millions USD
FY21:
−3.87
FY22:
−10.9
FY23:
29.2
FY24:
−18.3
FY25:
−4.51
(positive)
Change from FY21 to FY25
millions USD
FY21:
−19.3
FY22:
−20.9
FY23:
−50.5
FY24:
−58.9
FY25:
−51.2

All amounts in millions USD Data source:SEC EDGAR